Status | Study |
Completed |
Study Name: Cardio-respiratory Events During Ophthalmic Artery Chemotherapy for Retinoblastoma Under a Deep Anesthesia Condition: Retinoblastoma Date: 2016-05-01 |
Withdrawn |
Study Name: Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population Condition: Amblyopia Myopia Hyperopia Date: 2016-01-08 Interventions: Device: Spot photoscreener Scr |
Recruiting |
Study Name: PCI Imaging System in Pediatric Ophthalmology Condition: Retinoblastoma Date: 2015-11-05 Interventions: Procedure: Examination under anaesthetic (EUA) |
Recruiting |
Study Name: Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors Condition: Retinoblastoma Clear Cell Sarcoma Renal Cell Carcinoma Date: 2015-02-24 Interventions: Drug: Simvastatin The starting |
Recruiting |
Study Name: SPT Screening in Irradiated Hereditary Retinoblastoma Survivors Condition: Retinoblastoma Date: 2014-12-18 Interventions: Device: Magnetic resonance imaging MR imaging protocol should include a thin-slice (3-4 mm) short TI inv |
Completed |
Study Name: CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma Condition: Retinoblastoma Date: 2014-12-15 Interventions: Drug: carboplatin periocular injection |
Recruiting |
Study Name: Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma Condition: Retinoblastoma Retinal Neoplasms Date: 2005-09-12 Interventions: Drug: Carboplatin Drug: VP-16 |
Active, not recruiting |
Study Name: Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma Condition: Retinoblastoma Retinal Neoplasm Date: 2005-09-12 Interventions: Procedure: Enucleation |
Completed |
Study Name: Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome Condition: Von Hippel-Lindau Syndrome Date: 2004-08-12 Interventions: Drug: Ranibizumab |
Completed |
Study Name: EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome Condition: Hippel-Lindau Disease Date: 2003-03-07 Interventions: Drug: EYE001 |